Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12688/f1000research.25998.1 http://scihub22266oqcxt.onion/10.12688/f1000research.25998.1 32850116!7431966!32850116     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32850116&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       F1000Res 2020 ; 9 (?): ? Nephropedia Template TP {{tp|p=32850116|t=2020. Development of vaccines for SARS-CoV-2 |pdf=|usr=}}{{32850116}} gab.com Text Development of vaccines for SARS-CoV-2 JO: F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=32850116 #FOAvip COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a few months, huge efforts and resources by government, academia, and industry have been thrown into the race to develop a vaccine. This brief review summarizes and discusses the array of technologies being applied to vaccine development, highlighting the strengths and weaknesses of the various approaches. Twit Text FOAVip Development of vaccines for SARS-CoV-2 ????F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=32850116 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32850116 #FOAvip English Wikipedia <ref>{{Cite pmid|32850116}}</ref> Development of vaccines for SARS-CoV-2 #MMPMID32850116 Ng WH; Liu X; Mahalingam S F1000Res 2020[]; 9 (?): ? PMID32850116show ga COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a few months, huge efforts and resources by government, academia, and industry have been thrown into the race to develop a vaccine. This brief review summarizes and discusses the array of technologies being applied to vaccine development, highlighting the strengths and weaknesses of the various approaches. |*Viral Vaccines[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |China[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*prevention & control[MESH] |Humans[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*prevention & control[MESH] |SARS-CoV-2[MESH]Development of vaccines for SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing